3-Chlorophenyl (2E)-3-(6-bromo-2H-1,3-benzodioxol-5-yl)prop-2-enoate

Catalog No. :
ACXDXL529
CAS No. :
478259-32-4
Molecular Formula :
C16H10BrClO4
Molecular Weight :
381.61

IUPAC Name:3-chlorophenyl (E)-3-(6-bromobenzo[d][1,3]dioxol-5-yl)acrylate

3-Chlorophenyl (2E)-3-(6-bromo-2H-1,3-benzodioxol-5-yl)prop-2-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chlorophenyl (2E)-3-(6-bromo-2H-1,3-benzodioxol-5-yl)prop-2-enoate
IUPAC Name3-chlorophenyl (E)-3-(6-bromobenzo[d][1,3]dioxol-5-yl)acrylate
MDL No.MFCD02571388
Molecular FormulaC16H10BrClO4
Molecular Weight381.61
SMILESO=C(OC1=CC=CC(Cl)=C1)/C=C/C2=C(Br)C=C(OCO3)C3=C2
InChI KeyKJQGOSARTOROJQ-SNAWJCMRSA-N
Synonym3-CHLOROPHENYL (E)-3-(6-BROMO-1,3-BENZODIOXOL-5-YL)-2-PROPENOATE;2-Propenoic acid, 3-(6-bromo-1,3-benzodioxol-5-yl)-, 3-chlorophenyl ester
CAS No.478259-32-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXDXL529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGCPQ054 route compound structure diagram
    ACGCPQ05427452-00-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXDXL529 route product structure diagram
    ACXDXL529478259-32-4
Inquiry

2. ACXDXL529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVIFC207 route compound structure diagram
    ACVIFC2075279-32-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXDXL529 route product structure diagram
    ACXDXL529478259-32-4
Inquiry

Comments (0)